Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$306.88 - $380.0 $655,188 - $811,300
2,135 Added 11.4%
20,859 $7.89 Million
Q3 2023

Nov 13, 2023

SELL
$315.92 - $397.36 $56,549 - $71,127
-179 Reduced 0.95%
18,724 $5.95 Million
Q2 2023

Aug 14, 2023

BUY
$346.15 - $392.09 $69,230 - $78,418
200 Added 1.07%
18,903 $7.25 Million
Q1 2023

May 15, 2023

BUY
$323.56 - $373.36 $226,492 - $261,352
700 Added 3.89%
18,703 $6.98 Million
Q4 2022

Feb 13, 2023

BUY
$248.67 - $334.17 $335,704 - $451,129
1,350 Added 8.11%
18,003 $5.95 Million
Q3 2022

Nov 14, 2022

BUY
$263.81 - $337.27 $80,462 - $102,867
305 Added 1.87%
16,653 $4.4 Million
Q2 2022

Aug 12, 2022

BUY
$301.4 - $428.42 $118,751 - $168,797
394 Added 2.47%
16,348 $5.12 Million
Q1 2022

May 16, 2022

SELL
$379.46 - $424.54 $433,343 - $484,824
-1,142 Reduced 6.68%
15,954 $6.66 Million
Q4 2021

Feb 11, 2022

BUY
$373.53 - $434.12 $4.14 Million - $4.82 Million
11,093 Added 184.79%
17,096 $7.16 Million
Q3 2021

Nov 12, 2021

SELL
$396.76 - $455.92 $520,152 - $597,711
-1,311 Reduced 17.92%
6,003 $2.48 Million
Q2 2021

Aug 13, 2021

BUY
$372.36 - $412.07 $364,912 - $403,828
980 Added 15.47%
7,314 $2.9 Million
Q4 2020

Feb 12, 2021

BUY
$319.05 - $363.32 $59,024 - $67,214
185 Added 3.01%
6,334 $2.3 Million
Q3 2020

Nov 12, 2020

SELL
$280.08 - $347.78 $748,933 - $929,963
-2,674 Reduced 30.31%
6,149 $2.07 Million
Q2 2020

Aug 12, 2020

BUY
$270.93 - $320.3 $214,034 - $253,037
790 Added 9.83%
8,823 $2.5 Million
Q1 2020

May 11, 2020

SELL
$243.44 - $359.98 $632,944 - $935,948
-2,600 Reduced 24.45%
8,033 $2.22 Million
Q4 2019

Feb 14, 2020

BUY
$281.18 - $322.05 $2.99 Million - $3.42 Million
10,633 New
10,633 $3.42 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.